Proteolysis targeting chimera (PROTAC)-driven antibody internalization of oncogenic cell surface receptors
Abstract Antibody-drug conjugates (ADCs) are increasingly used in clinic for multiple indications and may improve upon the activity of parental antibodies by delivering cytotoxic payloads into target cells. This activity is predicated upon internalization to release the cytotoxic payloads intracellu...
Saved in:
Main Authors: | Ezequiel J. Tolosa, Lin Yang, Jennifer Ayers-Ringler, Shinichiro Suzuki, Jayapal Reddy Mallareddy, Janet Schaefer-Klein, Mitesh Borad, Farhad Kosari, Amarnath Natarajan, Aaron S. Mansfield |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-12-01
|
Series: | Communications Biology |
Online Access: | https://doi.org/10.1038/s42003-024-07439-0 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Potential application of proteolysis targeting chimera (PROTAC) modification technology in natural products for their targeted protein degradation
by: Guliang Yang, et al.
Published: (2022-03-01) -
Influenza A virus hemagglutinin: from classical fusion inhibitors to proteolysis targeting chimera-based strategies in antiviral drug discovery
by: Francisco Javier Hermoso-Pinilla, et al.
Published: (2024-02-01) -
PROTAC technology for prostate cancer treatment
by: Zhen Wang, et al.
Published: (2025-01-01) -
«Dragons» and «Chimeras» of Hybrid Wars
by: A. Dimitrovska
Published: (2019-05-01) -
Towards a Quantitative Description of Proteolysis: Contribution of Demasking and Hydrolysis Steps to Proteolysis Kinetics of Milk Proteins
by: Mikhail M. Vorob’ev
Published: (2025-01-01)